Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020. http://www.ncbi.nlm.nih.gov/pubmed/32091533. Accessed 11 March 2020.
Spina S, Marrazzo F, Migliari M, Stucchi R, Sforza A, Fumagalli R. The response of Milan’s Emergency Medical System to the COVID-19 outbreak in Italy. London, England: Lancet; 2020. http://www.ncbi.nlm.nih.gov/pubmed/32119824. Accessed 11 March 2020.
World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 50. World Health Organization. 2020. https://apps.who.int/iris/handle/10665/331450.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
FB is a consultant for: Alcon (Fort Worth, Texas, USA), Alimera Sciences (Alpharetta, Georgia, USA), Allergan Inc (Irvine, California, USA), Bayer Shering-Pharma (Berlin, Germany), Bausch and Lomb (Rochester, New York, USA), Genentech (San Francisco, California, USA), Hoffmann-La-Roche (Basel, Switzerland), Novagali Pharma (Évry, France), Novartis (Basel, Switzerland), Sanofi-Aventis (Paris, France), Thea (Clermont-Ferrand, France), Thrombogenics (Heverlee, Belgium), and Zeiss (Dublin, USA). GQ is a consultant for: Alimera Sciences (Alpharetta, Georgia, USA), Allergan Inc (Irvine, California, USA), Amgen (Thousand Oaks, USA), Bayer Shering-Pharma (Berlin, Germany), Bausch and Lomb (Rochester, New York, USA), Heidelberg (Germany), KBH (Chengdu; China), Hoffmann-La-Roche (Basel, Switzerland), LEH Pharma (London, UK), Lumithera (Poulsbo; USA), Novartis (Basel, Switzerland), Topcon (Tokyo, Japan), Sandoz (Berlin, Germany), Sifi (Catania, Italy), Sooft-Fidea (Abano, Italy), Thea (Clermont-Ferrand, France), and Zeiss (Dublin, USA). The other authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Borrelli, E., Sacconi, R., Querques, L. et al. Taking the right measures to control COVID-19 in ophthalmology: the experience of a tertiary eye care referral center in Italy. Eye 34, 1175–1176 (2020). https://doi.org/10.1038/s41433-020-0880-6
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-020-0880-6
This article is cited by
-
Postponed care due to COVID-19 lockdown impact on visual acuity of retinal vein occlusion patients: a large cohort
Graefe's Archive for Clinical and Experimental Ophthalmology (2023)
-
Reasons for Delayed Anti-VEGF Treatment During COVID-19 Lockdown and Clinical Impact in Neovascular Age-Related Macular Degeneration
Ophthalmology and Therapy (2023)
-
Clinical operational considerations and responses to lockdown and reopening in the Covid-19 pandemic: experience of a tertiary ophthalmology centre in Singapore
Eye (2022)
-
Changes in patient visits and diagnoses in a large academic center during the COVID-19 pandemic
BMC Ophthalmology (2021)
-
The Effect of Treatment Discontinuation During the COVID-19 Pandemic on Visual Acuity in Exudative Neovascular Age-Related Macular Degeneration: 1-Year Results
Ophthalmology and Therapy (2021)